Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma
PaperCitations, authors & open-access status
Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 1,781 citations, 2021 year and bronze oa status.
1,781
Citations
2021
Year
bronze
OA Status